These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22425244)

  • 1. [Eruptive dysplastic nevi following melanotan use].
    Hueso-Gabriel L; Mahiques Santos L; Terrádez Mas L; Santonja López N
    Actas Dermosifiliogr; 2012 May; 103(4):329-31. PubMed ID: 22425244
    [No Abstract]   [Full Text] [Related]  

  • 2. [Eruptive nevi after injection of drugs marketed as melanotan II. The first two Swedish cases described].
    Burian E; Burian E
    Lakartidningen; 2013 Jan 30-Feb 5; 110(5):208-10. PubMed ID: 23451671
    [No Abstract]   [Full Text] [Related]  

  • 3. [Melanotan-induced lentigines and nevi].
    Thestrup-Pedersen K; Søndergaard K
    Ugeskr Laeger; 2011 Mar; 173(13):975. PubMed ID: 21453640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eruptive melanocytic naevi following melanotan injection.
    Cousen P; Colver G; Helbling I
    Br J Dermatol; 2009 Sep; 161(3):707-8. PubMed ID: 19575725
    [No Abstract]   [Full Text] [Related]  

  • 5. alpha-Melanocyte-stimulating hormone-induced eruptive nevi.
    Cardones AR; Grichnik JM
    Arch Dermatol; 2009 Apr; 145(4):441-4. PubMed ID: 19380666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.
    Schulze F; Erdmann H; Hardkop LH; Anemüller W; Rose C; Zillikens D; Fischer TW
    Eur J Dermatol; 2014; 24(1):107-9. PubMed ID: 24334249
    [No Abstract]   [Full Text] [Related]  

  • 7. Melanotan-associated melanoma in situ.
    Ong S; Bowling J
    Australas J Dermatol; 2012 Nov; 53(4):301-2. PubMed ID: 22724573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical melanocytic naevi following melanotan injection.
    Reid C; Fitzgerald T; Fabre A; Kirby B
    Ir Med J; 2013 May; 106(5):148-9. PubMed ID: 23914578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eruptive post-chemotherapy in situ melanomas and dysplastic nevi.
    Reutter JC; Long EM; Morrell DS; Thomas NE; Groben PA
    Pediatr Dermatol; 2007; 24(2):135-7. PubMed ID: 17461808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanotan-associated melanoma.
    Paurobally D; Jason F; Dezfoulian B; Nikkels AF
    Br J Dermatol; 2011 Jun; 164(6):1403-5. PubMed ID: 21564053
    [No Abstract]   [Full Text] [Related]  

  • 11. Eruptive Melanocytic Nevi: A Review.
    Burian EA; Jemec GBE
    Am J Clin Dermatol; 2019 Oct; 20(5):669-682. PubMed ID: 31119650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An eruptive pigmented lesion after melanotan injection.
    Ferrándiz-Pulido C; Fernández-Figueras MT; Quer A; Ferrándiz C
    Clin Exp Dermatol; 2011 Oct; 36(7):801-2. PubMed ID: 21933235
    [No Abstract]   [Full Text] [Related]  

  • 13. Change in moles linked to use of unlicensed "sun tan jab".
    Langan EA; Ramlogan D; Jamieson LA; Rhodes LE
    BMJ; 2009 Jan; 338():b277. PubMed ID: 19174439
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanotan and the posterior reversible encephalopathy syndrome.
    Kaski D; Stafford N; Mehta A; Jenkins IH; Malhotra P
    Ann Intern Med; 2013 May; 158(9):707-8. PubMed ID: 23648958
    [No Abstract]   [Full Text] [Related]  

  • 15. [Melanotan].
    Mahiques-Santos L
    Actas Dermosifiliogr; 2012 May; 103(4):257-9. PubMed ID: 22051769
    [No Abstract]   [Full Text] [Related]  

  • 16. Consider underlying body dysmorphic disorder in users of melanotan.
    Affleck A
    Br J Dermatol; 2010 Feb; 162(2):459-60. PubMed ID: 19919633
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of melanotan I and II in the general population.
    Evans-Brown M; Dawson RT; Chandler M; McVeigh J
    BMJ; 2009 Feb; 338():b566. PubMed ID: 19224885
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical features of dysplastic nevi.
    McBride A; Rivers JK; Kopf AW; Cockerell CJ; Bart RS; Grin CM; Silverman MK; Vossaert KA
    Dermatol Clin; 1991 Oct; 9(4):717-22. PubMed ID: 1934646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.
    Habbema L; Halk AB; Neumann M; Bergman W
    Int J Dermatol; 2017 Oct; 56(10):975-980. PubMed ID: 28266027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eruptive melanocytic nevi with satellite lesions following insulin treatment in a girl with type 1 diabetes mellitus.
    Kim DH; Lee JS; Koo DW; Jung KE
    J Dermatol; 2015 May; 42(5):547-8. PubMed ID: 25766430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.